Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exome | 8 | 2021 | 127 | 1.280 |
Why?
|
| Genetic Testing | 5 | 2023 | 535 | 0.860 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 39 | 0.510 |
Why?
|
| Physicians | 1 | 2021 | 673 | 0.470 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 171 | 0.470 |
Why?
|
| Genetic Variation | 4 | 2018 | 1351 | 0.410 |
Why?
|
| Genomics | 4 | 2023 | 720 | 0.410 |
Why?
|
| Computational Biology | 1 | 2014 | 528 | 0.400 |
Why?
|
| Intellectual Disability | 3 | 2016 | 186 | 0.370 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2008 | 13 | 0.340 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2008 | 35 | 0.340 |
Why?
|
| Neuropeptides | 1 | 2008 | 112 | 0.330 |
Why?
|
| Gene Duplication | 1 | 2008 | 125 | 0.320 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 176 | 0.310 |
Why?
|
| Gene Deletion | 1 | 2008 | 329 | 0.310 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 101 | 0.280 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 456 | 0.270 |
Why?
|
| Gallstones | 1 | 2004 | 14 | 0.260 |
Why?
|
| Glucuronosyltransferase | 2 | 2010 | 184 | 0.250 |
Why?
|
| Fabry Disease | 1 | 2023 | 6 | 0.240 |
Why?
|
| Mutation, Missense | 2 | 2015 | 276 | 0.230 |
Why?
|
| Cohort Studies | 3 | 2021 | 2767 | 0.220 |
Why?
|
| Phenotype | 4 | 2018 | 2378 | 0.220 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 131 | 0.220 |
Why?
|
| De Lange Syndrome | 2 | 2013 | 10 | 0.210 |
Why?
|
| BRCA1 Protein | 1 | 2023 | 200 | 0.210 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2021 | 18 | 0.200 |
Why?
|
| DNA Mutational Analysis | 2 | 2015 | 526 | 0.190 |
Why?
|
| Genome | 1 | 2023 | 372 | 0.180 |
Why?
|
| Genetics, Medical | 1 | 2019 | 52 | 0.170 |
Why?
|
| Loose Anagen Hair Syndrome | 1 | 2018 | 5 | 0.170 |
Why?
|
| Noonan Syndrome | 1 | 2018 | 5 | 0.170 |
Why?
|
| Hypopituitarism | 1 | 2018 | 19 | 0.170 |
Why?
|
| Cleft Palate | 1 | 2018 | 25 | 0.170 |
Why?
|
| Cardiac Myosins | 1 | 2018 | 18 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 2271 | 0.160 |
Why?
|
| Humans | 23 | 2023 | 86643 | 0.160 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 88 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 744 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 294 | 0.150 |
Why?
|
| Histone Acetyltransferases | 1 | 2016 | 38 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 36 | 0.140 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2015 | 41 | 0.140 |
Why?
|
| Genotype | 4 | 2010 | 1851 | 0.130 |
Why?
|
| Bartter Syndrome | 1 | 2015 | 3 | 0.130 |
Why?
|
| Transaminases | 1 | 2015 | 34 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 240 | 0.130 |
Why?
|
| Chloride Channels | 1 | 2015 | 42 | 0.130 |
Why?
|
| Mutation | 6 | 2016 | 3968 | 0.130 |
Why?
|
| Sudden Infant Death | 1 | 2015 | 25 | 0.130 |
Why?
|
| Genetic Counseling | 1 | 2015 | 100 | 0.130 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 62 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 91 | 0.130 |
Why?
|
| DNA | 2 | 2014 | 1294 | 0.120 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 232 | 0.120 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2013 | 5 | 0.120 |
Why?
|
| Micrognathism | 1 | 2013 | 11 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2015 | 180 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2015 | 319 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 4 | 2016 | 853 | 0.100 |
Why?
|
| Cell Cycle Proteins | 2 | 2013 | 388 | 0.100 |
Why?
|
| Glucuronides | 1 | 2010 | 34 | 0.100 |
Why?
|
| Proteins | 2 | 2013 | 777 | 0.100 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 49 | 0.090 |
Why?
|
| Adult | 5 | 2021 | 25648 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 636 | 0.090 |
Why?
|
| Female | 11 | 2023 | 44532 | 0.090 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 34 | 0.090 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 58 | 0.090 |
Why?
|
| Warfarin | 1 | 2009 | 103 | 0.080 |
Why?
|
| Genes | 1 | 2008 | 305 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1621 | 0.080 |
Why?
|
| Male | 9 | 2021 | 40965 | 0.070 |
Why?
|
| Base Sequence | 2 | 2015 | 2330 | 0.070 |
Why?
|
| Algorithms | 1 | 2014 | 1830 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2009 | 408 | 0.070 |
Why?
|
| Dairying | 1 | 2005 | 3 | 0.070 |
Why?
|
| Lactose | 1 | 2005 | 27 | 0.070 |
Why?
|
| Agriculture | 1 | 2005 | 38 | 0.060 |
Why?
|
| Adolescent | 3 | 2021 | 8981 | 0.060 |
Why?
|
| Age of Onset | 1 | 2004 | 310 | 0.060 |
Why?
|
| DNA Primers | 1 | 2004 | 543 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 1 | 2023 | 87 | 0.060 |
Why?
|
| Alleles | 2 | 2018 | 1128 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1801 | 0.060 |
Why?
|
| BRCA2 Protein | 1 | 2023 | 158 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 8489 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2005 | 394 | 0.050 |
Why?
|
| Direct-To-Consumer Screening and Testing | 1 | 2021 | 1 | 0.050 |
Why?
|
| Jews | 1 | 2021 | 42 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 937 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2018 | 677 | 0.050 |
Why?
|
| Aging | 1 | 2004 | 691 | 0.040 |
Why?
|
| Child | 2 | 2016 | 6927 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 394 | 0.040 |
Why?
|
| Facies | 1 | 2018 | 27 | 0.040 |
Why?
|
| Karyotype | 1 | 2018 | 33 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2016 | 3612 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2015 | 2379 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 5976 | 0.040 |
Why?
|
| Research | 1 | 2019 | 253 | 0.040 |
Why?
|
| Expert Testimony | 1 | 2018 | 46 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2705 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 476 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1991 | 0.040 |
Why?
|
| Specialty Boards | 1 | 2015 | 24 | 0.030 |
Why?
|
| Homozygote | 1 | 2015 | 200 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 257 | 0.030 |
Why?
|
| Consanguinity | 1 | 2015 | 73 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2023 | 2261 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 365 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2015 | 73 | 0.030 |
Why?
|
| Autopsy | 1 | 2015 | 116 | 0.030 |
Why?
|
| Syndrome | 1 | 2015 | 446 | 0.030 |
Why?
|
| Siblings | 1 | 2015 | 111 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2015 | 207 | 0.030 |
Why?
|
| Mass Screening | 1 | 2019 | 618 | 0.030 |
Why?
|
| Medicine | 1 | 2015 | 89 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 239 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2015 | 293 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2015 | 193 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 339 | 0.030 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2013 | 2 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 4213 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2010 | 1981 | 0.030 |
Why?
|
| Cause of Death | 1 | 2015 | 277 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2013 | 104 | 0.030 |
Why?
|
| Pedigree | 1 | 2015 | 966 | 0.030 |
Why?
|
| Zebrafish | 1 | 2015 | 309 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2013 | 152 | 0.030 |
Why?
|
| United States | 2 | 2019 | 6672 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 351 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 5417 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2010 | 49 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3030 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1673 | 0.020 |
Why?
|
| Glycosylation | 1 | 2010 | 129 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2009 | 28 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 347 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 25028 | 0.020 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2009 | 16 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2C9 | 1 | 2009 | 21 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 214 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 44 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 3046 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 596 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 68 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2009 | 127 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 1513 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 879 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 434 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 2894 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1054 | 0.020 |
Why?
|
| Lactose Tolerance Test | 1 | 2005 | 2 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2601 | 0.020 |
Why?
|
| Brain | 1 | 2015 | 2216 | 0.020 |
Why?
|
| Milk | 1 | 2005 | 53 | 0.020 |
Why?
|
| Africa | 1 | 2005 | 98 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 48 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 1135 | 0.020 |
Why?
|
| Europe | 1 | 2005 | 309 | 0.020 |
Why?
|
| Haplotypes | 1 | 2005 | 642 | 0.010 |
Why?
|
| Animals | 2 | 2015 | 26582 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2357 | 0.010 |
Why?
|